International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Chemotherapy-Induced Hand–Foot Syndrome: A Narrative Review of Prevention, Assessment, and Evidence-Based Nursing Management
| Author(s) | Sheikh aabidah akram, Kumarasamy AP, Vikram Singh Deora |
|---|---|
| Country | India |
| Abstract | Background Chemotherapy-induced Hand–Foot Syndrome (HFS), also known as palmar-plantar erythrodysesthesia, is a common dose-limiting cutaneous toxicity associated with several anticancer agents, particularly capecitabine, 5-fluorouracil, pegylated liposomal doxorubicin, and multikinase inhibitors. HFS can significantly impair patients' physical function, activities of daily living, treatment adherence, and overall quality of life. Early recognition, appropriate assessment, preventive interventions, and evidence-based nursing management are essential to minimize symptom severity and optimize treatment outcomes.12 Methods A narrative review methodology was adopted to synthesize current evidence regarding chemotherapy-induced HFS. Electronic databases, including PubMed, Scopus, Web of Science, and Google Scholar, were searched for English-language articles published between 2000 and 2025. Original research articles, clinical guidelines, systematic reviews, meta-analyses, and evidence-based practice recommendations focusing on prevention, assessment, and management of HFS were included. The evidence was synthesized narratively according to major thematic areas. Results The reviewed literature demonstrates that HFS is a multifactorial adverse effect resulting from the accumulation of chemotherapeutic agents in the skin, leading to inflammation and damage to keratinocytes and eccrine sweat glands. Early identification through standardized grading systems, patient education, prophylactic skin care, dose modification, topical therapies, and multidisciplinary nursing interventions effectively reduce symptom severit and improve treatment adherence. Evidence also supports the role of structured nursing assessment, patient counseling, and individualized supportive care in improving quality of life. Conclusion Chemotherapy-induced HFS remains a clinically significant toxicity affecting cancer treatment and patient well-being. Comprehensive prevention strategies, standardized assessment tools, and evidence-based nursing management are essential for minimizing treatment interruptions and improving clinical outcomes. Further high-quality prospective studies are needed to strengthen current recommendations and optimize supportive care practices. |
| Keywords | Hand–Foot Syndrome; Palmar-Plantar Erythrodysesthesia; Chemotherapy; Nursing Management; Prevention; Oncology Nursing. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 3, May-June 2026 |
| Published On | 2026-06-28 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i03.82524 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals